Literature DB >> 7065515

An index of risk for obstructive airways disease.

M W Higgins, J B Keller, M Becker, W Howatt, J R Landis, H Rotman, J G Weg, I Higgins.   

Abstract

Predictors of obstructive airways disease (OAD) have been identified, and models for estimating risk of developing OAD have been derived for the adult population of Tecumseh. Men and women 16 to 64 yr of age when first studied were reexamined after an average interval of 15 yr. Incidence rates of OAD increased with age and were higher in men than in women more than 45 yr of age. Incidence rates were significantly higher in men and women with low degrees of lung function initially, and in cigarette smokers, especially those who continued to smoke. Other risk factors included a physician's diagnosis of chronic bronchitis, or asthma, a history of cough, wheeze, shortness of breath, frequent upper or lower respiratory tract infections, bronchitis or pneumonia, leanness, and familial chronic bronchitis. Multiple logistic regression analyses identified combinations of risk factors that placed 70% of the male and 73% of the female incidence cases in the top 10% of the risk distribution. The excess risk of obstructive airways disease associated with cigarette smoking and reduced lung function and the benefits of stopping smoking are clearly apparent. For example, the risk of developing obstructive airways disease in the next 15 years is about 1 in 200 for a 45-yr-old male nonsmoker whose Vmax50 equals to 100% of predicted, if he doesn't take up smoking. The risk for a man of the same age who smokes 40 cigarettes a day and whose Vmax50 equals 80% of predicted is 1 in 5 or 6 if he doesn't cut down on his smoking and about 1 in 15 if he stops smoking.

Entities:  

Mesh:

Year:  1982        PMID: 7065515     DOI: 10.1164/arrd.1982.125.2.144

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  20 in total

Review 1.  Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

2.  A program for the prevention of lung diseases.

Authors:  K H Harnoncourt
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Effect of cigarette smoking on evolution of ventilatory lung function in young adults: an eight year longitudinal study.

Authors:  M S Jaakkola; P Ernst; J J Jaakkola; L W N'gan'ga; M R Becklake
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

Review 4.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

5.  John Hutchinson's mysterious machine.

Authors:  T L Petty
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

6.  Smoking, lung function, and body weight.

Authors:  B Nemery; N E Moavero; L Brasseur; D C Stănescu
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-22

Review 7.  Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease.

Authors:  H Koyama; D M Geddes
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

Review 8.  Natural history of emphysema.

Authors:  Omar A Minai; Joshua Benditt; Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

9.  Decline of lung function and development of chronic airflow limitation: a longitudinal study of non-smokers and smokers in Busselton, Western Australia.

Authors:  J K Peat; A J Woolcock; K Cullen
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

10.  Association of Nonobstructive Chronic Bronchitis With Respiratory Health Outcomes in Adults.

Authors:  Pallavi P Balte; Paulo H M Chaves; David J Couper; Paul Enright; David R Jacobs; Ravi Kalhan; Richard A Kronmal; Laura R Loehr; Stephanie J London; Anne B Newman; George T O'Connor; Joseph E Schwartz; Benjamin M Smith; Lewis J Smith; Wendy B White; Sachin Yende; Elizabeth C Oelsner
Journal:  JAMA Intern Med       Date:  2020-05-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.